Crystalvue Medical Corporation
Crystalvue Medical Corporation designs, produces, and sells medical devices worldwide. The company offers optical coherence tomography, retinal cameras, tonometers, lens edgers, and gastroenterology supplies, as well as ODM/OEM services for automated nucleic acid extraction instrument and PCR system. It also sells minimal invasive endoscopic instrument supplies. The company was founded in 2009 an… Read more
Crystalvue Medical Corporation (6527) - Net Assets
Latest net assets as of : NT$- TWD
Based on the latest financial reports, Crystalvue Medical Corporation (6527) has net assets worth NT$- TWD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$-) and total liabilities (NT$-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Crystalvue Medical Corporation - Net Assets Trend (None–None)
This chart illustrates how Crystalvue Medical Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Crystalvue Medical Corporation (None–None)
The table below shows the annual net assets of Crystalvue Medical Corporation from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Crystalvue Medical Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Crystalvue Medical Corporation Competitors by Market Cap
The table below lists competitors of Crystalvue Medical Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ARYZTA N
MU:YZA
|
$21.08K |
|
KEY TRONIC
BE:KT1
|
$21.12K |
|
Synbio Tech Inc.
TWO:1295
|
$21.14K |
|
YAHOO JAPAN
BE:YOJ
|
$21.16K |
|
TAURON
MU:1T5
|
$21.07K |
|
LS Networks Corp. Ltd.
KQ:000680
|
$21.05K |
|
SUN INTL RC-08
F:RY1B
|
$21.02K |
|
WeLeader Biomedical Co., Ltd.
TWO:7713
|
$21.02K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Crystalvue Medical Corporation's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Crystalvue Medical Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Crystalvue Medical Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Crystalvue Medical Corporation's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,796,147,300
- Average return on equity (ROE) among peers: 10.94%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Crystalvue Medical Corporation (6527) | NT$- | N/A | N/A | $21.08K |
| St.Shine Optical Co Ltd (1565) | $5.39 Billion | 29.48% | 0.60x | $147.19 Million |
| Nang Kuang Pharmaceutical Co Ltd (1752) | $2.19 Billion | 9.94% | 0.50x | $46.91 Million |
| Maxigen Biotech Inc (1783) | $1.14 Billion | 7.68% | 0.11x | $53.63 Million |
| SciVision Biotech Inc (1786) | $1.02 Billion | -2.16% | 0.07x | $107.95 Million |
| Bioteque (4107) | $1.88 Billion | 15.46% | 0.25x | $198.92 Million |
| Chi Sheng Chemical (4111) | $1.22 Billion | 12.60% | 0.47x | $41.85 Million |
| Sunder Biomedical Tech. Co., Ltd. (4115) | $790.45 Million | 1.68% | 0.80x | $2.11K |
| BenQ Medical Technology (4116) | $1.10 Billion | 2.62% | 0.78x | $25.45 Million |
| Pacific Hospital Supply Co Ltd (4126) | $2.26 Billion | 10.49% | 0.61x | $128.74 Million |
| Unicon Optical Co., Ltd. (4150) | $963.23 Million | 21.57% | 0.59x | $22.68 Million |